Healthcare & Life Sciences
Myosin Therapeutics
United Statesmyosintherapeutics.com/
Myosin Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Myosin Therapeutics
Myosin Therapeutics is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Myosin Therapeutics develops first-in-class therapies that target molecular motor proteins, such as non-muscle myosin II, to treat oncology and central nervous system diseases including glioblastoma, and is currently enrolling patients for a Phase 1/2 clinical trial in glioblastoma.
Explore Myosin Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.